Hypersensitivity to ticagrelor and low response to clopidogrel: a case report
Asia Pacific Allergy
;
(4): 51-53, 2017.
Article
in English
| WPRIM
| ID: wpr-750085
ABSTRACT
Ticagrelor is widely used to treat acute coronary syndrome. Hypersensitivity reaction of ticagrelor is rarely recognized. A low response to clopidogrel, which occurs in up to 23% of patients, is an independent risk factor for stent thrombosis. Management of patients with a low response to clopidogrel and ticagrelor hypersensitivity who are undergoing antithrombotic therapy remains to be a challenge. Herein, we report a patient with low response to clopidogrel and ticagrelor hypersensitivity, who was successfully managed using aspirin and warfarin.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Thrombosis
/
Warfarin
/
Stents
/
Aspirin
/
Risk Factors
/
Acute Coronary Syndrome
/
Hypersensitivity
Type of study:
Etiology study
/
Risk factors
Limits:
Humans
Language:
English
Journal:
Asia Pacific Allergy
Year:
2017
Type:
Article
Similar
MEDLINE
...
LILACS
LIS